Monocyte/HDL Cholesterol Ratios as a New Inflammatory Marker in Patients with Schizophrenia
Monocyte/HDL Cholesterol Ratios as a New Inflammatory Marker in Patients with Schizophrenia is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Monocyte/HDL Cholesterol Ratios as a New Inflammatory Marker in Patients with Schizophrenia have?
Monocyte/HDL Cholesterol Ratios as a New Inflammatory Marker in Patients with Schizophrenia has 15 citations in the OpenAlex counts ScholarIQ stores.
When was Monocyte/HDL Cholesterol Ratios as a New Inflammatory Marker in Patients with Schizophrenia published?
Monocyte/HDL Cholesterol Ratios as a New Inflammatory Marker in Patients with Schizophrenia has 2023 year in the ScholarIQ index.
What is the open-access status of Monocyte/HDL Cholesterol Ratios as a New Inflammatory Marker in Patients with Schizophrenia?
Monocyte/HDL Cholesterol Ratios as a New Inflammatory Marker in Patients with Schizophrenia has gold oa status in the ScholarIQ index.
What is the DOI of Monocyte/HDL Cholesterol Ratios as a New Inflammatory Marker in Patients with Schizophrenia?
The DOI for Monocyte/HDL Cholesterol Ratios as a New Inflammatory Marker in Patients with Schizophrenia is on the source record.
What is the PMID of Monocyte/HDL Cholesterol Ratios as a New Inflammatory Marker in Patients with Schizophrenia?
The PMID for Monocyte/HDL Cholesterol Ratios as a New Inflammatory Marker in Patients with Schizophrenia is on the source record.
What is the OpenAlex record for Monocyte/HDL Cholesterol Ratios as a New Inflammatory Marker in Patients with Schizophrenia?
The OpenAlex for Monocyte/HDL Cholesterol Ratios as a New Inflammatory Marker in Patients with Schizophrenia is on the source record.